Headquartered on the University of Delaware’s STAR Campus, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership dedicated to advancing biopharmaceutical manufacturing innovation through technology and workforce development. Fueled by the collective expertise of 200 member organizations across the U.S., NIIMBL develops rapid, flexible, and cost-efficient manufacturing technologies and supports advancements in world-leading biopharmaceutical workforce development.
$15.4M awarded to projects that include a Delaware organization.
Delaware organizations have participated on a total of 24 NIIMBL-funded projects.
$4.7M awarded directly to projects led by a Delaware organization.
NIIMBL has subsidized almost $551K in membership fees for Delaware-based academic institutions and small- to medium-sized businesses.
Delaware organizations represent nearly 9% of NIIMBL’s national membership.
65% are small companies with 500 or fewer employees.
Since 2017, NIIMBL’s workforce has expanded from 6 to 49 employees, representing a yearly growth rate exceeding 50%.
NIIMBL directly employs 49 employees with 9 additional positions to be filled in 2024.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
